South Africa Polymerase Chain Reaction Market Size & Outlook
Related Markets
South Africa polymerase chain reaction market highlights
- The South Africa polymerase chain reaction market generated a revenue of USD 112.5 million in 2023 and is expected to reach USD 114.4 million by 2030.
- The South Africa market is expected to grow at a CAGR of 0.2% from 2024 to 2030.
- In terms of segment, conventional pcr was the largest revenue generating type in 2023.
- Conventional PCR is the most lucrative type segment registering the fastest growth during the forecast period.
Polymerase chain reaction market data book summary
| Market revenue in 2023 | USD 112.5 million |
| Market revenue in 2030 | USD 114.4 million |
| Growth rate | 0.2% (CAGR from 2023 to 2030) |
| Largest segment | Conventional pcr |
| Fastest growing segment | Conventional PCR |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Conventional PCR |
| Key market players worldwide | Thermo Fisher Scientific Inc, Danaher Corp, Abbott Laboratories, Bio-Rad Laboratories Inc, Agilent Technologies Inc, Qiagen NV, Roche Holding AG ADR, Standard BioTools Inc, Stilla, Microsynth |
Other key industry trends
- In terms of revenue, South Africa accounted for 0.4% of the global polymerase chain reaction market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Middle East & Africa, South Africa polymerase chain reaction market is projected to lead the regional market in terms of revenue in 2030.
- South Africa is the fastest growing regional market in Middle East & Africa and is projected to reach USD 114.4 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Polymerase Chain Reaction Market Scope
Polymerase Chain Reaction Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Microsynth | View profile | 11-50 | Balgach, Sankt Gallen, Switzerland, Europe | https://www.microsynth.ch/ |
| Stilla | View profile | 1-10 | San Francisco, California, United States, North America | https://wearestilla.com/ |
| Standard BioTools Inc | View profile | 539 | 2 Tower Place, Suite 2000, South San Francisco, CA, United States, 94080 | https://www.standardbio.com |
| Qiagen NV | View profile | 5900 | Hulsterweg 82, Venlo, LI, Netherlands, 5912 PL | https://www.qiagen.com |
| Bio-Rad Laboratories Inc | View profile | 8030 | 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547 | https://www.bio-rad.com |
| Agilent Technologies Inc | View profile | 17700 | 5301 Stevens Creek Boulevard, Santa Clara, CA, United States, 95051 | https://www.agilent.com |
| Danaher Corp | View profile | 63000 | 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701 | https://www.danaher.com |
| Thermo Fisher Scientific Inc | View profile | 122000 | 168 Third Avenue, Waltham, MA, United States, 02451 | https://www.thermofisher.com |
| Abbott Laboratories | View profile | 114000 | 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 | https://www.abbottinvestor.com |
| Roche Holding AG ADR | View profile | 103605 | Grenzacherstrasse 124, Basel, Switzerland, 4070 | https://www.roche.com |
South Africa polymerase chain reaction market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to polymerase chain reaction market will help companies and investors design strategic landscapes.
Conventional pcr was the largest segment with a revenue share of 9.87% in 2023. Horizon Databook has segmented the South Africa polymerase chain reaction market based on conventional pcr covering the revenue growth of each sub-segment from 2018 to 2030.
South Africa has a high burden of infectious diseases, such as HIV/AIDS and tuberculosis. The country has a large population prone to these diseases and requires focused detection tests & treatment. Increasing mortality rates and healthcare expenditures by government & private entities are expected to drive the market.
An increase in mortality and morbidity rates is anticipated to lead to an increased prevalence of diseases, resulting in the high use of PCR products. For instance, the South African government collaborated with UNO to improve healthcare measures to decrease mortality and increase life expectancy.
The rise in the prevalence of cancer in South Africa has led to an increase in the need for advanced genomics techniques to detect cancer. According to Lancet, a medical journal, South Africa will witness a 78% increase in cancer cases by 2030.
Reasons to subscribe to South Africa polymerase chain reaction market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of South Africa polymerase chain reaction market databook
-
Our clientele includes a mix of polymerase chain reaction market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the South Africa polymerase chain reaction market , including forecasts for subscribers. This country databook contains high-level insights into South Africa polymerase chain reaction market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
South Africa polymerase chain reaction market size, by product, 2018-2030 (US$M)
South Africa Polymerase Chain Reaction Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
